GlassScriptPhysician profile
Ryon Thomas Wiska
NPI 1649621004
$10,430.29
in general payments reported to CMS, 2019-2025
34 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,204 · 2020: $1,469 · 2021: $1,618 · 2022: $722 · 2023: $1,557 · 2024: $1,739 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,988 · Travel and Lodging: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,988.19 |
| Travel and Lodging | $1,429.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $2,998.28 | 2019-2022 | |
| Stryker Corporation | $1,656.08 | 2019-2025 | Prostep, Actishield, Ortholoc 3di |
| Pinnacle, INC | $1,466.45 | 2019-2025 | |
| Arthrex, INC. | $611.73 | 2024-2025 | |
| Kerecis Limited | $468.25 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $430.61 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $348.19 | 2021 | |
| Depuy Synthes Sales INC. | $316.40 | 2021-2025 | Motoband, Foot Osteotomy Wedge System, Minibunion |
| Paragon 28, INC. | $241.80 | 2019-2024 | Bun-Yo-Matic |
| Mimedx Group, INC. | $241.06 | 2024-2025 | |
| Cardiovascular Systems INC. | $222.92 | 2019-2021 | |
| Organogenesis INC. | $200.42 | 2021-2025 | Apligraf, Puraply |
| Medical Device Business Services, INC. | $190.59 | 2019-2021 | |
| Acumed LLC | $169.45 | 2023-2025 | Acumed, Osteomed |
| Horizon Therapeutics Plc | $142.40 | 2020-2023 | Krystexxa |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Extremity Systems, LLC | $129.30 | 2019 | |
| Paratek Pharmaceuticals, INC. | $106.45 | 2024-2025 | Nuzyra |
| Amgen INC. | $71.52 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $52.79 | 2019-2023 | Grafix Pl |
| Kci USA, INC. | $46.51 | 2019-2023 | Snap, Activ.A.C. |
| Tactile Systems Technology INC | $40.86 | 2025 | Nimbl, Flexitouch Plus |
| Wright Medical Technology, INC. | $31.39 | 2019 | |
| Bioventus LLC | $27.57 | 2019 | |
| Orthofix Medical, INC. | $26.05 | 2020-2022 | |
| Convatec INC. | $25.30 | 2022 | |
| Medartis INC. | $25.20 | 2021 | |
| Surgenex LLC | $25.06 | 2025 | Surmatrix, Renograft, Ardeograft |
| Janssen Pharmaceuticals, INC | $22.70 | 2021 | |
| Hartmann USA, INC. | $18.73 | 2022 | |
| Biocomposites INC | $18.22 | 2019 | |
| Inari Medical, INC. | $16.87 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.42 | 2020 | |
| Linvatec Corporation | $13.91 | 2022 | |
| Grt US Holding, INC. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryon Wiska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.